1. Serum nitric oxide (NO) levels (determined by its products of oxida
tion) were assessed in nonpregnant women, normal pregnant women and pa
tients suffering from mild pre-eclampsia (MPE), severe pre-eclampsia (
SPE), chronic hypertension (CHT) and CHT with pre-eclampsia (CHT+PE).
The levels of NO products were significantly reduced during pregnancy
in MPE (P<0.001), CHT+PE (P<0.01) and SPE (P<0.05), Significant reduct
ions of NO products were also observed in puerperium (P<0.001) in all
groups except CHT+PE (P<0.05). 2. In normal pregnancy, three events we
re related to NO levels: (1) negative correlations were found between
the levels of nitrite (r=-0.73, P=0.0003), nitrate (r=-0.53, P=0.017)
and the number of weeks of gestation; (2) in the caesarean section gro
up, the levels of NO at puerperium were significantly lower (P<0.05) t
han those during pregnancy; and (3) there was a significant reduction
in NO levels in the pregnant women carrying male fetuses as compared w
ith female fetuses (P<0.05). 3. In SPE, the patients with a family his
tory of hypertension had lower levels of NO compared with the patients
without such a history (P<0.05). 4. A negative correlation was observ
ed between systolic blood pressure, diastolic blood pressure and NO le
vels in MPE (r=-0.62, P=0.013 and r=-0.68, P=0.0049 respectively) and
SPE (r=-0.72, P=0.004 and r=-0.53, P=0.037 respectively). 5. In SPE, p
ositive correlations were observed between platelet count and nitrite
(r=0.67, P=0.006) and nitrate levels (r=0.56, P=0.028). 6. In MPE, pat
ients with anti-hypertensive treatment showed significantly (P<0.05) h
igher levels of NO compared with the non-treated patients. 7. NO may b
e important in the physiopathology of hypertension during pregnancy, a
lthough several factors may affect its levels.